FDA Approves Brentuximab Vedotin With Lenalidomide and Rituximab for R/R LBCL in Patients Ineligible for Stem Cell Transplant or CAR T-Cell Therapy Sharon Worcester February 12, 2025

FDA Approves Brentuximab Vedotin With Lenalidomide and Rituximab for R/R LBCL in Patients Ineligible for Stem Cell Transplant or CAR T-Cell Therapy Sharon Worcester https://www.medscape.com/viewarticle/fda-approves-brentuximab-vedotin-lenalidomide-and-rituximab-2025a10003pc February 12, 2025